🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
HI-PAD is a placebo controlled double-blind randomized pilot clinical trial...
Status
Completed
Location
Northwestern University
Start Date
2018-01-01
Trial ID
NCT03363165
The purpose of this study is to determine if Engensis (VM202) is safe and e...
Status
Completed
Location
Diablo Clinical Research
Start Date
2012-08
Trial ID
NCT01475786
The purpose of this study is to determine the safety and efficacy of bilate...
Status
Completed
Location
Arizona Research Center
Start Date
2016-04
Trial ID
NCT02427464
Treatments Being Tested
A double-blind, randomized, placebo-controlled, single-center, 12-month pha...
Status
Withdrawn
Location
Translational Pain Research, Brigham and Women's Hospital
Start Date
2019-11
Trial ID
NCT04087941
Treatments Being Tested
The purpose of this study is to evaluate whether intramuscular injections o...
Status
Completed
Location
Cardiology PC
Start Date
2010-07-09
Trial ID
NCT01064440
Treatments Being Tested
The purpose of this study is to explore the overall safety profile and dura...
Status
Completed
Location
Arizona Research Center
Start Date
2019-02-04
Trial ID
NCT04055090
This study will assess the safety and efficacy of using gene therapy via in...
Status
Terminated
Location
Central Research Associates, Inc.
Start Date
2017-06-27
Trial ID
NCT02563522
Treatments Being Tested
The purpose of this study is to evaluate the safety of VM202 (Engensis) dir...
Status
Completed
Location
Seoul National University Hospital
Start Date
2007-01
Trial ID
NCT01422772
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability and prel...
Status
Completed
Location
Minneapolis Heart Institute Foundation/ Abbott Northwestern Hospital
Start Date
2007-04-03
Trial ID
NCT00696124
Treatments Being Tested
The purpose of this open label, Phase I/II, dose-escalation, 3-cohort, mult...
Status
Completed
Location
Diablo Clinical Research Hospital
Start Date
2010-02
Trial ID
NCT01002235
Treatments Being Tested